About this Research Topic
Drug repurposing is a rapidly developing field aimed at utilizing approved drugs for novel applications. However, the field confronts several critical challenges that demand immediate attention: 1. How to effectively screen and identify a potential new use of the approved drugs, along with gaining an in-depth understanding of these novel applications; 2. How to balance the safety, and efficiency and avoid the potential side effect of repurposed drugs; 3. Drug repurposing research should be patient-centered, based on clinical needs and scientific evidence, primarily focusing on unmet clinical needs; 4. The study should be based on scientific hypotheses, which may stem from the known mechanisms of the approved drugs or predicted through computational biology and bioinformatics methods.
The scope of this Research Topic includes, but is not limited to, the following aspects:
• Discovery and validation of new drug indications: Including preclinical and clinical studies, and experiments studies to explore and validate the efficacy, safety, and potential side effects for drug repositioning.
• Insights into the drug mechanisms of new application: Using molecular biology, cell biology, biochemistry, and other methods to reveal the mechanisms of action and potential toxicity of drugs within novel indications.
• Drug-target interactions and toxicology studies: Exploring the performance between drugs and novel molecular targets, and analyzing their related potential toxic effects.
• Translational medical research and drug safety assessment: Particular emphasis on safety assessments and toxicity monitoring within novel indications.
Keywords: Drug repurposing, Drug toxicology, Clinical needs, New Indications, Drug target, Drug mechanism, New Drug Development Strategy
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.